Literature DB >> 22090111

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors.

Ravindra P Veeranna1, Muzammel Haque, David A Davis, Min Yang, Robert Yarchoan.   

Abstract

Hypoxia and hypoxia-inducible factors (HIFs) play an important role in the Kaposi's sarcoma-associated herpesvirus (KSHV) life cycle. In particular, hypoxia can activate lytic replication of KSHV and specific lytic genes, including the replication and transcription activator (RTA), while KSHV infection in turn can increase the levels and activity of HIFs. In the present study, we show that hypoxia increases the levels of mRNAs encoding KSHV latency-associated nuclear antigen (LANA) in primary effusion lymphoma (PEL) cell lines and also increases the levels of LANA protein. Luciferase reporter assays in Hep3B cells revealed a moderate activation of the LANA promoter region by hypoxia as well as by cotransfection with degradation-resistant HIF-1α or HIF-2α expression plasmids. Computer analysis of a 1.2-kb sequence upstream of the LANA translational start site identified six potential hypoxia-responsive elements (HRE). Sequential deletion studies revealed that much of this activity was mediated by one of these HREs (HRE 4R) oriented in the 3' to 5' direction and located between the constitutive (LTc) and RTA-inducible (LTi) mRNA start sites. Site-directed mutation of this HRE substantially reduced the response to both HIF-1α and HIF-2α in a luciferase reporter assay. Electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP) assays demonstrated binding of both HIF-1α and HIF-2α to this region. Also, HIF-1α was found to associate with RTA, and HIFs enhanced the activation of LTi by RTA. These results provide evidence that hypoxia and HIFs upregulate both latent and lytic KSHV replication and play a central role in the life cycle of this virus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090111      PMCID: PMC3255810          DOI: 10.1128/JVI.05167-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant.

Authors:  J S Cannon; D Ciufo; A L Hawkins; C A Griffin; M J Borowitz; G S Hayward; R F Ambinder
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter.

Authors:  Hong Li; Takashi Komatsu; Bruce J Dezube; Kenneth M Kaye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter.

Authors:  J S Knight; M A Cotter; E S Robertson
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

4.  Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.

Authors:  J Jeong; J Papin; D Dittmer
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.

Authors:  T Piolot; M Tramier; M Coppey; J C Nicolas; V Marechal
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus.

Authors:  D A Davis; A S Rinderknecht; J P Zoeteweij; Y Aoki; E L Read-Connole; G Tosato; A Blauvelt; R Yarchoan
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

7.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 transcriptional activator Rta is an oligomeric DNA-binding protein that interacts with tandem arrays of phased A/T-trinucleotide motifs.

Authors:  Wei Liao; Yong Tang; Yu-Liang Kuo; Bao-Ying Liu; Chi-Jie Xu; Chou-Zen Giam
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 8.  The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression.

Authors:  John T West; Charles Wood
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

9.  HIF-2alpha regulates glyceraldehyde-3-phosphate dehydrogenase expression in endothelial cells.

Authors:  Krista K Graven; Deepti Bellur; Brian D Klahn; Shawna L Lowrey; Ed Amberger
Journal:  Biochim Biophys Acta       Date:  2003-04-15

10.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia.

Authors:  Muzammel Haque; David A Davis; Victoria Wang; Isabelle Widmer; Robert Yarchoan
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  20 in total

Review 1.  Reprogramming of cellular metabolic pathways by human oncogenic viruses.

Authors:  John G Purdy; Micah A Luftig
Journal:  Curr Opin Virol       Date:  2019-11-22       Impact factor: 7.090

2.  The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains.

Authors:  Muzammel Haque; K G Kousoulas
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

3.  Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors:  Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2019

4.  KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.

Authors:  Tao Ma; Harsh Patel; Savalan Babapoor-Farrokhran; Renty Franklin; Gregg L Semenza; Akrit Sodhi; Silvia Montaner
Journal:  Angiogenesis       Date:  2015-06-20       Impact factor: 9.596

5.  The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1α and causes its degradation via the proteasome pathway.

Authors:  Muzammel Haque; Konstantin G Kousoulas
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

Review 6.  Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.

Authors:  Kevin Brulois; Jae U Jung
Journal:  Cytokine Growth Factor Rev       Date:  2014-06-21       Impact factor: 7.638

7.  Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.

Authors:  Liming Zhang; Caixia Zhu; Yi Guo; Fang Wei; Jie Lu; Jing Qin; Shuvomoy Banerjee; Junwen Wang; Hong Shang; Subhash C Verma; Zhenghong Yuan; Erle S Robertson; Qiliang Cai
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.

Authors:  Kevin Y Kim; Steve B Huerta; Chie Izumiya; Don-Hong Wang; Anthony Martinez; Bogdan Shevchenko; Hsing-Jien Kung; Mel Campbell; Yoshihiro Izumiya
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

9.  IRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania Infection.

Authors:  Akil Hammami; Tania Charpentier; Mélina Smans; Simona Stäger
Journal:  PLoS Pathog       Date:  2015-06-05       Impact factor: 6.823

Review 10.  Metabolic landscapes in sarcomas.

Authors:  Richard Miallot; Franck Galland; Virginie Millet; Jean-Yves Blay; Philippe Naquet
Journal:  J Hematol Oncol       Date:  2021-07-22       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.